Many patients with prostate cancer are treated with androgen-deprivation therapy. However, patients receiving androgen-deprivation therapy often experience higher levels of fatigue, depression, and cognitive impairment. In a new study published by Hoogland et al in the journal Cancer, researchers investigated whether inflammation in the body, a side effect of androgen-deprivation therapy, contributes to these symptoms, and they pinpointed a specific inflammation marker that may be associated with increased fatigue in this group of patients.
Recent research has shed new light on the carcinogenic effect of exposure to ultraviolet (UV) radiation, laying the groundwork for improvements in skin cancer risk stratification and prevention. A study published by Lei Wei, PhD, and colleagues in Science Advances detailed a method to measure the abundance of cancer-related early changes to skin tissue long before the damage becomes visible to the eye.
|